Cancer research , General interest , Risk and Prevention
Is Cancer More Serious If You Also Have Another Disease?

When cancer develops in someone with other diseases, it can be more serious, according to a recent annual report from several national cancer organizations. “Cancer does not occur in isolation,” says Lawrence Shulman, MD, in commenting on the report. “It occurs in a human being, who may have other medical problems.”

January 27, 2014
1
Care for adults , Care for children , General interest , Stem Cell/Bone Marrow Transplant
What’s the Difference Between Donating Bone Marrow and Donating Stem Cells?

Stem cell transplantation (sometimes called bone marrow transplants) is a treatment for certain forms of cancer, such as leukemia, lymphoma, and multiple myeloma, as well as other diseases. But before a patient can receive a transplant, stem cells must be collected from a donor (an allogeneic donation) or from the […]

November 22, 2013
1
Cancer research , General interest , Health and wellness , Prostate Cancer , Risk and Prevention , Testicular Cancer
Can a Vasectomy Increase a Man’s Risk of Prostate or Testicular Cancer?

By Mark Pomerantz, MD There has been some uncertainty surrounding this question, but recent studies have demonstrated that having a vasectomy has no effect on the risk of prostate or testicular cancer. Older data – from studies tracking disease rates across broad population groups – suggested a modest connection, while […]

November 8, 2013
0

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Catch Me if You Can: Finding Cancer Cells that Hide in Plain Sight: https://t.co/SBccqKKMmY #CarTCellTherapy https://t.co/HYTgpdbi1s
Dana-Farber @danafarber
What is chronic #GVHD and how can I manage it? https://t.co/ShjxErJLYW https://t.co/22qxgu1h74
Dana-Farber @danafarber
Doctors use a PD-L1 test to determine whether a patient may benefit from immune checkpoint inhibitors. Learn more:… https://t.co/NwZhiStver

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.